'''Aripiprazole''' (also called '''Abilify''') is an [[antipsychotic]] medicine used for treatment of [[schizophrenia]], [[bipolar disorder]], [[autism]] and an adjuvant for [[Depression (mental illness)|major depression]], which was first approved by [[Food and Drug Administration]] of the [[United States]] in November 2002. The first approval was for the treatment of [[schizophrenia]]. Later approvals were for bipolar disorder and depression. Common side effects include increase of [[blood sugar]], [[vomit]]ing, [[nausea]] and dizziness. 
 
 
 {{med-stub}} 
 [[Category:Drugs used in psychiatry]] 
 [[Category:Organonitrogen compounds]] 
 [[Category:Organochlorides]]